lifestyle.brightsfuture.com

Author: HAEMONETICS CORPORATION

New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

April 24, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

April 1, 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

March 30, 2026
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

March 11, 2026
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

March 11, 2026
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

March 9, 2026
Haemonetics Acquires Vivasure Medical Limited

January 9, 2026
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

January 7, 2026
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference

January 2, 2026
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

November 9, 2025